SARS-CoV-2 infection induces ZBP1-dependent PANoptosis in bystander cells

Respiratory viral infections frequently precipitate an uncontrolled release of pro-inflammatory cytokines, a phenomenon often termed a cytokine storm. It was already known that this excessive inflammatory response serves as a primary driver of lung injury and systemic organ failure in affected patients. While the initial viral replication causes direct cellular damage, the mechanisms sustaining chronic inflammation after the initial viral load decreases remain poorly understood. Scientists have observed that tissue destruction often extends beyond the cells directly harboring the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), suggesting a potent bystander effect. The role of programmed cell death pathways in these uninfected neighboring cells has emerged as a significant area of investigation for understanding disease progression. Previous models of viral pathogenesis often focused exclusively on the direct cytopathic effects of viral entry and replication within the host cell. This absence of evidence motivated a comprehensive study into the molecular signals that bridge infected cells and the subsequent death of bystander tissues.

This research investigates the specific molecular pathways through which SARS-CoV-2 infection triggers Z-DNA Binding Protein 1 (ZBP1)-dependent PANoptosis in uninfected bystander cells. The study evaluates how the activation of the Cyclic GMP-AMP Synthase (cGAS) and Stimulator of Interferon Genes (STING) pathway in infected cells influences neighboring cell viability. One primary objective involved determining if the secretion of Cyclic GMP-AMP (2'3'cGMP-AMP), Tumor Necrosis Factor-alpha (TNF-α), and Interferon-beta (IFN-β) acts as a paracrine signal for cell death. The researchers hypothesized that these extracellular molecules induce the degradation of Adenosine Deaminase Acting on RNA 1 (ADAR1) via STING-mediated autophagy. By characterizing the accumulation of Z-nucleic acid, the team sought to link metabolic changes to the activation of the ZBP1 complex. The investigation also aimed to clarify how these intracellular sensors recognize non-self or altered-self ligands in the absence of direct viral replication. Ultimately, the work aimed to identify whether targeting the cGAS-STING axis could alleviate the severe pathology linked to both SARS-CoV-2 and Influenza A Virus (IAV).

The investigative team used a combination of in vitro cell cultures and in vivo mouse models to study the effects of SARS-CoV-2 and IAV infections. They employed genetic knockout techniques to generate STING-deficient mice, allowing for the assessment of this protein's role in the inflammatory cascade. To track the signaling process, the researchers quantified the levels of secreted 2'3'cGMP-AMP, TNF-α, and IFN-β using specialized assays. The degradation of ADAR1 was monitored through Western blotting and immunofluorescence to confirm autophagy-mediated breakdown. The presence of Z-nucleic acid and the subsequent formation of the ZBP1-dependent PANoptosis complex were analyzed using molecular imaging and biochemical markers. Researchers also used pharmacological inhibitors to block the cGAS pathway and observe changes in cellular survival. Statistical frameworks were then applied to compare the pathological outcomes between wild-type and cGAS-inhibited or STING-knockout groups.

Infection with SARS-CoV-2 induces ZBP1-dependent PANoptosis in bystander cells by activating the cGAS-STING pathway within the initially infected cell population. The results showed that these infected cells secrete high concentrations of 2'3'cGMP-AMP, TNF-α, and IFN-β into the surrounding microenvironment. These molecules subsequently trigger STING-induced autophagy in uninfected bystander cells, which facilitates the rapid degradation of the ADAR1 protein. The resulting depletion of ADAR1 leads to the significant accumulation of Z-nucleic acid, which directly activates the ZBP1 protein to initiate PANoptosis. Experimental data showed that knocking out STING or pharmacologically inhibiting the cGAS pathway effectively reduced the incidence of bystander cell death. The reduction in PANoptosis directly correlated with a decrease in the persistent inflammatory response and linked tissue damage. These interventions were found to alleviate the severe lung pathology and inflammatory markers in mouse models challenged with either SARS-CoV-2 or IAV.

The study concludes that ZBP1-dependent PANoptosis in bystander cells is a primary driver of persistent inflammation and tissue damage during respiratory viral infections. These findings suggest that the cGAS-STING-ZBP1 signaling axis represents a viable therapeutic target for mitigating the clinical severity of COVID-19. By preventing the degradation of ADAR1 or blocking the accumulation of Z-nucleic acid, clinicians may be able to protect uninfected lung tissue from collateral damage. The researchers emphasize that this mechanism is not unique to SARS-CoV-2 but also plays a role in the pathogenesis of the IAV. Future research should focus on developing small-molecule inhibitors that can safely disrupt this paracrine death signaling in human patients. The identification of these pathways offers a new perspective on how respiratory viruses manipulate host cell death to ensure sustained inflammation. This work provides a foundational molecular framework for understanding how localized viral infections translate into widespread, life-threatening inflammatory conditions.